skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8129

Novel topical therapy for mild-to-moderate plaque psoriasis: focus on calcitriol

Review

(3166) Views  (1459) Full article downloads

Author: Lutz Kowalzick

Published Date September 2009 Volume 2009:2 Pages 153 - 159
DOI: http://dx.doi.org/10.2147/CCID.S5758

Lutz Kowalzick

Department of Dermatology and Allergology, HELIOS Vogtland-Klinikum Plauen GmbH Plauen, Germany

Abstract: The benefits of vitamin D derivatives for the treatment of chronic plaque psoriasis are well documented. Of importance is how compatible they are with, and how they compare to, other established treatments for psoriasis. This paper reviews 15 studies with calcitriol 3 µg g-1 ointment (Silkis®/Vectical™ ointment; Galderma Laboratories) applied twice daily for up to 52 weeks. The ointment was found to be effective and safe for the treatment of mild-to-moderate plaque psoriasis including sensitive skin areas. Calcitriol 3 µg g-1 ointment was found to be as effective as, or even superior to, other established treatment modalities and more highly tolerated than other local treatment modalities in most studies’ comparisons. It could be combined with other psoriasis treatment modalities such as ultraviolet B phototherapy or topical corticosteroids in order to achieve a faster response and in order to reduce the risk of adverse events.

Keywords: 1,25-dihydroxyvitamin D3, calcitriol, psoriasis, therapy
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University

  • American Acne and Rosacea Society

    The American Acne and Rosacea Society (AARS), is a 501(c)(6) non-profit organization dedicated to elevating the understanding and treatment of acne and rosacea.